MoneyWorks4Me

Venus Remedies - Quaterly Results

29 May 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 1485.30 millions, about 15.35% up against Rs. 1287.70 millions recorded during the year-ago period.The Net Profit of the company vaulted to 211.57% to Rs. 75.40  millions from Rs. 24.20 millions in the previous quarter.The company reported a good operating profit of 242.70 millions compared to 97.80 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1485.30 1287.70 15.35 5376.60 5767.10 -6.77 5376.60 5767.10 -6.77
Other Income 32.40 24.70 31.17 101.70 84.30 20.64 101.70 84.30 20.64
PBIDT 242.70 97.80 148.16 717.00 772.50 -7.18 717.00 772.50 -7.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 242.70 97.80 148.16 717.00 772.50 -7.18 717.00 772.50 -7.18
Depreciation 80.60 73.60 9.51 313.70 325.80 -3.71 313.70 325.80 -3.71
PBT 162.10 24.20 569.83 403.30 446.70 -9.72 403.30 446.70 -9.72
TAX 86.70 0.00 0.00 113.70 -43.20 -363.19 113.70 -43.20 -363.19
Deferred Tax 86.70 0.00 0.00 113.70 -43.20 -363.19 113.70 -43.20 -363.19
PAT 75.40 24.20 211.57 289.60 489.90 -40.89 289.60 489.90 -40.89
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 16.34 7.59 115.15 13.34 13.39 -0.44 13.34 13.39 -0.44
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..